Biogen International Gmbh v. Amneal Pharmaceuticals LLC

Case: 21-1078 Document: 94 Page: 1 Filed: 10/31/2022

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit ______________________ BIOGEN INTERNATIONAL GMBH,

BIOGEN MA INC.,

Plaintiffs-Appellants v.

AMNEAL PHARMACEUTICALS LLC, ALKEM

LABORATORIES LTD., HETERO USA INC., CIPLA LIMITED, CIPLA USA INC., HETERO LABS LIMITED, HETERO LABS LIMITED UNIT-III, LUPIN ATLANTIS HOLDINGS SA, MSN

LABORATORIES PRIVATE LTD., MSN

PHARMACEUTICALS INC., PHARMATHEN S.A., PRINSTON PHARMACEUTICAL INC., S&B

PHARMA, INC., SANDOZ INC., SHILPA MEDICARE LIMITED, SUN PHARMACEUTICAL INDUSTRIES, INC., SUN PHARMA GLOBAL FZE, SUN

PHARMACEUTICAL INDUSTRIES LIMITED,

ZYDUS PHARMACEUTICALS (USA) INC., TWI PHARMACEUTICALS INC., TWI

PHARMACEUTICALS USA, INC.,

Defendants-Appellees

ACCORD HEALTHCARE INC., GRAVITI

PHARMACEUTICALS INC., GRAVITI

PHARMACEUTICALS PVT. LTD., IMPAX

LABORATORIES LLC, MACLEODS PHARMA USA, INC., MACLEODS PHARMACEUTICALS LTD., SLAYBACK PHARMA LLC, SLAYBACK PHARMA INDIA LLP, TORRENT PHARMA INC., TORRENT Case: 21-1078 Document: 94 Page: 2 Filed: 10/31/2022

2 BIOGEN INTERNATIONAL GMBH v. AMNEAL PHARMACEUTICALS LLC

PHARMACEUTICALS LTD., WINDLAS

HEALTHCARE PVT. LTD.,

Defendants ______________________ 2021-1078, 2021-1084, 2021-1086, 2021-1087, 2021-1088, 2021-1090, 2021-1091, 2021-1092, 2021-1093, 2021-1094, 2021-1095, 2021-1096, 2021-1097, 2021-1098, 2021-1441 ______________________

Appeals from the United States District Court for the District of Delaware in Nos. 1:17-cv-00823-MN, 1:17-cv- 00825-MN, 1:17-cv-00828-MN, 1:17-cv-00845-MN, 1:17-cv- 00846-MN, 1:17-cv-00847-MN, 1:17-cv-00850-MN, 1:17-cv- 00851-MN, 1:17-cv-00853-MN, 1:17-cv-00855-MN, 1:17-cv- 00856-MN, 1:17-cv-00872-MN, 1:17-cv-00874-MN, 1:17-cv- 00954-MN, and 1:20-cv-01159-MN, Judge Maryellen Noreika. ______________________ ON MOTION ______________________ ORDER

Upon consideration of appellants’ unopposed motion to voluntarily dismiss the above-captioned consolidated ap- peals pursuant to Federal Rule of Appellate Procedure 42(b) with each party to bear its own costs upon dismissal, IT IS ORDERED THAT: (1) The motion is granted. The above-captioned ap- peals are dismissed. (2) Any other pending motion is denied as moot. Case: 21-1078 Document: 94 Page: 3 Filed: 10/31/2022

BIOGEN INTERNATIONAL GMBH v. AMNEAL 3 PHARMACEUTICALS LLC

(3) Each side shall bear its own costs.

FOR THE COURT October 31, 2022 /s/ Peter R. Marksteiner Date Peter R. Marksteiner Clerk of Court ISSUED AS A MANDATE: October 31, 2022